Triangle Race for the Cure

Thank you!

On behalf of our Board, Race volunteers, staff, and especially the thousands of women you will help us serve, thank you for making our 2009 Komen NC Triangle Race for the Cure® a huge success!

The Race had almost 23,000 registered racers and thousands more spectators and volunteers. At $1.75 million raised to date and still counting, we are well on our way to meeting our $2 million goal!

Donations will be collected AND count toward pledge prizes until the end of June – remember that every dollar gets us one step closer to the cure!

If you would like to make a donation, click here!

Click here to login to your Race Center!

For Age Group Competitive Race Results, click here!

For Survivors Competitive Race Results, click here!

2009 Race Photos Coming Soon!

Donate to Spirit of Komen

Remembering Our Founder

Remembering Our Founder

(Read More)
Share your memories of Jeanne

Share your memories of Jeanne

(Read More)

Breast Cancer News

Jun 22, 2009 Oncotype DX® and Clinical Characteristics Influence Chemotherapy Decisions in Early Breast Cancer

According to research conducted at the Dana-Farber Cancer Institute, among women with early breast cancer who underwent testing with Oncotype DX®, decisions about the need for chemotherapy were influenced by the Oncotype DX recurrence score as well as by the size and grade of the cancer. These results were presented at the 2009 annual meeting of the American Society of Clinical Oncology.

Jun 15, 2009 Denosumab Provides Bone Benefits in Prostate and Breast Cancer

Among prostate patients treated with androgen deprivation therapy, the investigational drug denosumab increases bone density and reduces the risk of fractures. Denosumab also improves bone density in breast cancer patients treated with aromatase inhibitors. These were the results of two studies presented at the 2009 annual meeting the American Society of Clinical Oncology (ASCO).

Jun 10, 2009 Partial Breast Irradiation Appears Safe and Feasible for Early Breast Cancer

Partial breast irradiation (PBI) appears to produce the same overall survival results as whole-breast radiation (WBRT) in women with early-stage breast cancer; however, more research will be necessary before this investigational treatment replaces WBRT as the standard of care in this patient group. The results of this study were presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida.